The president of the Oswaldo Cruz Foundation in Brazil (Fiocruz’s Institute), Nísia Trindade, said on Tuesday that the Oxford-AstraZeneca COVID-19 vaccine will start arriving in Brazil in February, reported G1.

Brazil’s institute should receive two million doses in the first two weeks of the month and start producing up to 700,000 daily doses, starting from the third week. The immunizer will be called Covid-Fiocruz in Brazil.